Back to search

Article

The potential of fetal cell therapy for osteogenesis imperfecta using placenta derived stem cells

2013-01-01

Abstract excerpt

Human mesenchymal stromal/stem cells (MSC) isolated from aborted first trimester fetal bone marrow (BM) hold promise for use in tissue engineering applications and cell-based therapies due to their advantageous characteristics compared to their adult BM-MSC counterparts; faster growth kinetics, active telomerase, smaller size and higher differentiation potency. However, their isolation is restricted ethically and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d3d59d70-ff1e-5a62-bc23-bf1fd39f4d0a
DOI
10.25560/40291
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The potential of fetal cell therapy for osteogenesis imperfecta using placenta derived stem cellsDOI 10.25560/40291
Select a neighboring publication to make it the new centre.